Company / Capital Expenditures
Xenetic Biosciences, Inc. Capital Expenditures History
FY2016-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$9.3K
FY2018
5-year range
-
FY2016-FY2018
Trend
-44.8%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $1,663 to $9,264 over the past 2 years.
Based on SEC 10-K filings.
$9,264 in FY2018.
Improved from $1,663 to $9,264 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2018, capital expenditures decreased 44.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $9.3K | -44.8% |
| FY2017 | $16.8K | +909.8% |
| FY2016 | $1.7K | -97.9% |
As of FY2018 · SEC 10-K · Updated Jun 28, 2026